Selective Modification of Streptozotocin at the C3 Position to Improve Its Bioactivity as Antibiotic and Reduce Its Cytotoxicity Towards Insulin-Producing Β Cells
Antibiotics - Switzerland
doi 10.3390/antibiotics9040182
Full Text
Open PDFAbstract
Available in full text
Date
April 15, 2020
Authors
Publisher
MDPI AG